| scholarly article | Q13442814 |
| P2093 | author name string | David R Flum | |
| Rebecca Symons | |||
| Richard Thirlby | |||
| Scott Steele | |||
| Steve Kwon | |||
| Mark Meissner | |||
| Rick Billingham | |||
| Surgical Care and Outcomes Assessment Program Collaborative | |||
| P2860 | cites work | Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial | Q57651026 |
| Prevention of fatal postoperative pulmonary embolism by low-dose heparin | Q66694962 | ||
| Can we really prevent postoperative pulmonary emboli? | Q66915164 | ||
| Postoperative pulmonary embolism after hospital discharge. An underestimated risk | Q68077435 | ||
| Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin Cy 216: a multicentre, double-blind, randomized, controlled, clinical trial versus placebo (STEP). STEP-Study Group | Q69364610 | ||
| Subcutaneous heparin and postoperative wound hematomas. A prospective, double-blind, randomized study | Q69563698 | ||
| Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo | Q71200603 | ||
| Prophylaxis against fatal postoperative pulmonary embolism | Q72664082 | ||
| Are symptomatic endpoints acceptable in venous thromboprophylactic studies? | Q74590375 | ||
| Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin | Q81443648 | ||
| Washington State's approach to variability in surgical processes/Outcomes: Surgical Clinical Outcomes Assessment Program (SCOAP) | Q81487316 | ||
| Adherence to surgical care improvement project measures and the association with postoperative infections | Q84461362 | ||
| The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism | Q24670353 | ||
| Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q28213383 | ||
| Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) | Q28284893 | ||
| Making health care safer: a critical analysis of patient safety practices | Q28346232 | ||
| Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer | Q34120902 | ||
| Acute pulmonary embolism 1: pathophysiology, clinical presentation, and diagnosis | Q34130631 | ||
| Twenty-one-year trends in the use of inferior vena cava filters | Q34336184 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 | ||
| Venous thromboembolism in the outpatient setting | Q34581299 | ||
| Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process | Q36416906 | ||
| Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study | Q37074678 | ||
| Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study | Q37460063 | ||
| Prevention of venous thromboembolism: a key patient safety priority | Q37561377 | ||
| Prevention of Fatal Postoperative pulmonary embolism by low doses of heparin. Reappraisal of results of international multicentre trial | Q39424378 | ||
| Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery | Q39638109 | ||
| Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis? | Q39942623 | ||
| Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988. | Q43532936 | ||
| Thromboprophylaxis rates in US medical centers: success or failure? | Q44663280 | ||
| How long after surgery does the risk of thromboembolism persist? | Q45208812 | ||
| A 10-year analysis of venous thromboembolism on the surgical service: the effect of practice guidelines for prophylaxis | Q46317074 | ||
| Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery | Q47206731 | ||
| Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement | Q47324889 | ||
| A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project | Q48739118 | ||
| A reassessment of needs and practice patterns in pharmacologic prophylaxis of venous thromboembolism following elective major surgery. | Q50163577 | ||
| A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. | Q50549660 | ||
| Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. | Q50977960 | ||
| Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. | Q51025158 | ||
| Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. | Q53244487 | ||
| Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. | Q53259170 | ||
| Excess Length of Stay, Charges, and Mortality Attributable to Medical Injuries During Hospitalization | Q56610728 | ||
| Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry | Q57216106 | ||
| P433 | issue | 5 | |
| P921 | main subject | venous thromboembolism | Q9397786 |
| P304 | page(s) | 596-603, 603.e1 | |
| P577 | publication date | 2011-08-25 | |
| P1433 | published in | Journal of the American College of Surgeons | Q15723630 |
| P1476 | title | Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery | |
| P478 | volume | 213 |
| Q35991445 | Differences in perioperative care at low- and high-mortality hospitals with cancer surgery |
| Q61808939 | Existing practice of perioperative management of colorectal surgeries in a regional cancer institute and compliance with ERAS guidelines |
| Q87423170 | Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS(®)) Society recommendations |
| Q64953414 | Impact of sequential implementation of multimodal perioperative care pathways on colorectal surgical outcomes |
| Q47792202 | Incidence and Risk Factors of Venous Thromboembolism After Orthopaedic Foot and Ankle Surgery |
| Q35096008 | Infection and venous thromboembolism in patients undergoing colorectal surgery: what is the relationship? |
| Q35832135 | Procedure-specific venous thromboembolism prophylaxis: a paradigm from colectomy surgery |
| Q90655258 | Risk factors for post-discharge venous thromboembolism in patients undergoing colorectal resection: a NSQIP analysis |
| Q47684630 | The Use of Surgical Care Improvement Projects in Prevention of Venous Thromboembolism |
| Q34480121 | Thromboembolic Complications and Prophylaxis Patterns in Colorectal Surgery. |
| Q42644826 | Venous thromboembolism in colorectal surgery: skip SCIP or comply? |
| Q37104836 | Venous thromboembolism prophylaxis |
Search more.